Mc. Miller et al., SYNTHESIS AND ANTITUMOR-ACTIVITY OF BORONATED DIPEPTIDES CONTAINING AROMATIC-AMINO-ACIDS, Anticancer research, 17(5A), 1997, pp. 3299-3306
N-[(Trimethylamine-boryl-carbonyl]-L-tryptophan methyl ester and N[(tr
imethylamine-boryl)-carbonyl]-L-histidine methyl ester were obtained b
y synthesis using triphenylphosphine/carbon tetrachloride or dicyclohe
xyl-carbodiimide as coupling agents, respectively. Both agents reduced
L-1210 lymphoid leukemia DNA, RNA, and protein syntheses with the lar
gest reductions occurring in DNA synthesis. Reductions in DNA synthesi
s appear to be mediated by inhibition of key enzyme activities (i.e.,
DNA polymerase a, IMP dehydrogenase, and PRPP amido transferase). Thes
e agents had little effect on in vitro L-1210 DNA topoisomerase II act
ivity at 100 mu M but were able to cause synergistic increases in prot
ein-linked DNA break when combined with etoposide (VP16). It was shown
that these agents significantly reduced protein kinase C mediated pho
sphorylation of human topoisomerase II in vitro. Thus, inhibition of t
opoisomerase II phosphorylation may be a mechanism by which these agen
ts and VP-16 are synergistic in causing protein-linked DNA breaks.